Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis

Published:2017-02 Issue: Volume:83 Page:27-38
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Westergren-Thorsson Gunilla,Hedström Ulf,Nybom Annika,Tykesson Emil,Åhrman Emma,Hornfelt Marie,Maccarana Marco,van Kuppevelt Toin H.,Dellgren Göran,Wildt Marie,Zhou Xiao-Hong,Eriksson Leif,Bjermer Leif,Hallgren Oskar

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference50 articles.

1. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development;Abramsson;Genes Dev.,2007

2. Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis;Alhasan;J. Biol. Chem.,2014

3. Hyaluronic acid: perspectives in lung diseases;Allegra;Handb. Exp. Pharmacol.,2012

4. Proteoglycan deposition in pulmonary fibrosis;Bensadoun;Am. J. Respir. Crit. Care Med.,1996

5. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis;Bjoraker;Am. J. Respir. Crit. Care Med.,1998

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The extracellular heparan sulfatase SULF2 limits myeloid IFNβ signaling and Th17 responses in inflammatory arthritis;Cellular and Molecular Life Sciences;2024-08-14

2. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326;Toxicology and Applied Pharmacology;2024-05

3. Extracellular Matrix as a Driver of Chronic Lung Diseases;American Journal of Respiratory Cell and Molecular Biology;2024-04

4. Exploring therapeutic targets for molecular therapy of idiopathic pulmonary fibrosis;Science Progress;2024-04

5. The extracellular heparan sulfatase SULF2 limits myeloid IFNβ signaling and Th17 responses in inflammatory arthritis;2024-03-14